Specialized dendritic cells (DC) 1 have been identified in lymphoid organs of mouse and rat (1-3). In all tissues, the frequency of DC is <1% of nucleated cells, as confirmed using a monoclonal antibody (Ab) specific for mouse DC (4). Methods for enriching DC are available (2, 3, 5). As a result, several distinctive functions of DC have been established. DC are potent stimulators of mixed leukocyte reactions (MLR) (3, 6-8) and accessory cells for several immune responses (2, 9-11). Recently, it has been shown that selective elimination of DC with monoclonal cytotoxic Ab and complement ablates MLR-stimulating capacity and accessory function in mouse spleen and spleen-adherent cells (12). The study of immune responses in man requires that the equivalent of the rodent DC be identified.
5 × 10 -5 M 2-mercaptoethanol (Eastman Kodak, Rochester, NY), 100 U/ml penicillin, 20/lg/ ml gentamycin (Schering Corp., Kenilworth, N J), and 5-10% serum. Fetal calf serum (FCS; Flow Laboratories, Inc., Rockville, MD) and newborn calf serum (NBCS; North American Biologicals, Miami, FL) were heat inactivated at 56°C for 30 min. Human serum was prepared from 1 U of whole A + blood with no additives (Greater New York Blood Center, New York) after 4 h of clotting at 4°C, clarification by centrifugation, and storage at -70°C.
Microscopy, Staining, and Cytochemist~y. To examine cells in suspension by light microscopy, we centrifuged (400 g, 10 min, room temperature) 2 × 105 cells onto 12-mm circular cover slips (Propper Manufacturing Co., Long Island City, NY, CGS, distributed by SGA Scientific, Bloomfield, N J) coated with 75 ~g/ml poly-L-lysine (PLL, type VII, Sigma Chemical Co., St. Louis, MO), and incubated the cover slips for 20 min in RPMI 1640 to allow spreading. For phase contrast, cells were fixed with 1.25% glutaraldehyde in phosphate-buffered saline (PBS) for 15-30 rain. To make lysosomes visible, cells were exposed to acridine orange (Allied Chemical Corp., Morristown, N J), 2.5 ~g/ml culture medium at 37°C for 20 min, rinsed, and mounted in medium for immediate viewing with a fluorescent microscope as described (14) . Giemsa (10% in PBS, Fisher Scientific Co., Pittsburgh, PA) staining was for 10-20 min on cytocentrifuged specimens fixed 10 min in absolute methanol. Endogenous myeloperoxidase and exogenous horseradish peroxidase (type II, Sigma Chemical Co.) were visualized in glutaraldehyde-fixed cells exposed to 0.4 mg/ml 3,3'diaminobenzidine tetrahydrochloride (grade II, Sigma Chemical Co.) and 0.1% hydrogen peroxide (Mallinckrodt Inc., St. Louis, MO) in 0.1 M tris, pH 7.5, for 10 rain at 20°C. Nonspeeifie esterase staining with alphanaphthyl-butyrate (Sigma Chemical Co.) was exactly according to Li et al. (15) .
For transmission electron microscopy (EM), cells were fixed in a mixture of 1.25% glutaraldehyde and 1% osmium tetroxide, stained en bloc with 0.25% uranyl acetate, and embedded in Epon as described (1) . For scanning EM, cells on cover slips were fixed in 1.25% glutaraldehyde/ PBS, washed, and stored in 0.1 M sucrose in 0.1 osmium cacodylate pH 7.4. Just before examination, the cover slips were dehydrated in ethanol, transferred to amyl acetate, and critical-point dried (Hitachi CTI, Tokyo, Japan) in CO2. Specimens were coated with gold (Polaron EM coating unit, E5000, Polaron Instruments Inc., Doylestown, PA) and examined with a high resolution Hitachi scanning electron microscope (HHS/2R) at 20 kv, at a tilt angle of 30 ° (16).
Endocytic Tests. Soluble horseradish peroxidase was used as a marker for pinocytosis as described (17) . Zymosan (Sigma Chemical Co.) and latex (1.1 /ira, The Dow Chemical Co., Indianapolis, IN) were used to monitor phagoeytosis at particle/cell ratios of 20:1 and 200:1, respectively, for 1 h at 37°C.
Indicator EoJthrocytes (E):
Sheep erythroeytes (Scott Labs, FiskeviUe, RI) and bovine erythrocytes (Rockland Inc., Gilbertsville, PA) were obtained in alsevers and used within 2 wk of arrival. For E rosetting, washed sheep E at 5% vol/vol in RPMI 1640 were treated with 0.02 U of Vibrio cholerae neuraminidase (En) (Calbiochem-Behring Corp., LaJolla, CA) per ml at 37°C for 45 min and washed three times (18) ; alternatively, washed sheep E were treated with 2 aminoethylisothiouronium bromide (EAET) (Calbiochem-Behring Corp.) exactly by the method of Kaplan et al. (19) . Both En and EAET rosetted >80% of nonadherent PBMC, but <5% of B cell-enriched fractions. Sheep E coated with antibody (EA), IgM (EIgM), and IgM plus mouse complement (EIgMC) were prepared as described (5) . E-anti-human Ig were prepared using saline-washed bovine E and chromic chloride coupling (20) . Rabbit anti-human F(ab)'2 IgG fragment serum was affinity purified on human IgG linked to cyanogen bromide-activated Sepharose 4B (Pharmaeia Fine Chemicals, Div. Pharmaeia Inc., Piscataway, NJ). E antihuman Ig bound >80% of B cell and <5% ofT cell-enriched fractions. Rosettes were formed in suspension (50 indicator cells per leucocyte were spun into a pellet) or on monolayers (1 × 107 to 2 × 107 indicator cells were spun onto 12-mm cover slips in 13-mm glass cylinders).
Immunofluorescence. All reagents for immunofluorescence were diluted in 5% NBCS-RPMI 1640-0.02% sodium azide. Two heteroantisera were directly labeled with fluorochrome: rhodamine-coupled F(ab)'2 goat anti-human IgG, IgM, and IgD (N. L. Cappel Laboratories, Cochranville, PA), and rhodamine-coupled F(ab)'~ rabbit anti-human glycoprotein 29/33 (anti-HLA-DR [21] , a generous gift of Dr. Shu Man Fu of The Rockefeller University). A large group of mouse monoclonal Ab were visualized by indirect immunofluoresence: anti-HLA (61D2 [22] , 1 t~g/ml, Bethesda Research Laboratories, Rockville, MD), anti-HLA-DR (59.5, 1 ~g/ml; and OKIal [23] , 1/40 of ascites, Ortho Pharmaceutical, Raritan, N J); antimonocyte (63D3, 10/.tg/ml; 61D3 [22] , 1/Lg/ml BRL; OKMI [24] , 50 #g/ml, Ortbo Pharmaceutical; and MI/70, rat anti-mouse "Mac-l" [25] , culture supernatant kindly supplied by Dr. T. Springer, Harvard University, Boston, MA); anti-Fc receptor (clone 3G8 [26] , 30 ~tg/ml, kindly provided by Dr. J. Unkeless and Dr. H. Fleit of The Rockefeller University); anti-leukocyte common antigen (T29/33 [27] , 1:300 dilution of ascites kindly supplied by Dr. I. S. Trowbridge, Salk Institute, La Jolla, CA); anti-human T cells (OKT 3 [28, 29] , pan T cell Ag, 0.6/.tg/ml; OKT6 [29, 30] , common thymocyte and Langerhans cell Ag, 1.2/*g/ml; OKT8, I28, 29], suppressor cytotoxic Ag, 50 ~g/ml, Ortho Pharmaceutical). Cells on PLL~coated cover slips were exposed to the primary Ab for 60 min at 4°C, rinsed in PBS, exposed to biotinylated horse anti-mouse IgG (Vector Laboratories, Burlingame, CA) at 50 btg/ml for 30 rain at 4°C, rinsed in PBS, and overlaid with fluoresceinated avidin (Vector Laboratories) at 100 ~g/ml for 30 min at 4°C, rinsed, fixed in 10% formalin/PBS for 20 min, mounted in glycerol, and viewed by epifluorescence (Zeiss photomicroscope II, Carl Zeiss, Inc., New York). To detect intracellular Ig, ceils on PLL-coated cover slips were formalin fixed, rinsed in PBS, exposed to absolute methanol for 30 s, rinsed in PBS, and treated with rhodamine anti-human Ig, as above. This technique detects intracellular Ig in plasma cells from tonsil. (Table It) . Our starting population was a concentrated leukocyte fraction (buffycoat) derived from 400 ml of blood by the Greater New York Blood Center. PBMC were recovered on Ficoll 400/sodium diatrizoate (Histopaque 1.077, Sigma Chemical Co,) with a yield after three washes of 4 X 108 to 10 X l0 s mononuclear cells per buffycoat. Leukocyte subpopulations were identified by standard cytologic and surface markers as described in results.
Enriched Populations of T Cells, Monocytes, B Cells, and DC
5 × 107 PBMC were plated in 5% FCS medium on 100-mm plastic tissue culture plates (Falcon 3003, Falcon Labware, Div. of Becton, Dickinson & Co., Oxnard, CA) for 1 h at 37°C. Nonadherent cells were removed with five rinses of RPMI 1640 and used as a source of T cells. The T cells were purified on nylon wool according to Julius et al. (31) . 10 × 107 to 20 × 107 nonadherent PBMC in 10% NBCS medium were loaded onto 3 g of nylon wool (Leukopak, Fenwal Lab, Division of Travenol, Deerfield, IL) in a 30-cc disposable plastic syringe, incubated at 37°C for 45 rain, eluted dropwise over 15 rain, and washed three times in RPMI 1640 before use. The population was >97% T cells, <3% monocytes, and <1% DC. Alternatively, nonadherent PBMC were separated into E rosette positive and negative fractions after rosetting with a 50:l ratio of En to PBMC and centrifugation on Ficoll/diatrizoate (17) . E, were lysed in ammonium chloride and the fractions washed three times before use. The E + fraction was >90% T cells, <10% monocytes, and <1% DC. The E-or non-T cell fraction was <20% T celts, 30-50% Ig-positive cells, 8-30% monocytes, and 2-10% DC.
Adherent PBMC were incubated for 16 h at 37°C in 5% FCS medium. About one-half the cells had released from the plates (released once) and were reattached in fresh medium to another 100-ram plastic plate for 1 h. The populations that adhered after overnight culture, or after the readherence step, were highly enriched in monocytes (80-90%) and had some small lymphocytes (5-15%) and DC (1-6%). Monocytes were eluted from the plates after treatment with phosphate saline supplemented with 10 mM ethylenediaminetetraacetic acid (Fisher Scientific Co., Pittsburgh, PA), pH 7.4, for 30 rain at 4°C, or were dislodged by vigorous pipetting.
Cells that did not readhere (released twice) after overnight culture were used as a source of enriched B cells and DC. The population was either rosetted with E anti-human Ig (50:1 ratio ofE anti-Ig/PBMC; 4°C, 20 min) or floated directly in bovine plasma albumin (BPA; Armour Pharmaceutical, Chicago, IL). 2 × 107 to 4 × 10 7 cells (+/-rosettes) were resuspended in 4 ml BPA, d = t.082, and overlaid with BPA at 1.047 (2 hal). The columns were centrifuged at 10,000 g for 15 min at 4°C, to provide low density (1.047:1.080) interface and high density (pellet) fractions that were harvested and washed 3 times in RPMI 1640. The low density population could be additionally depleted of monocytes by a final adherence on plastic. The low density fraction (2 × 106 to 5 × 106 cells/buffycoat) contained 20-60% DC, 10-25% monocytes, and the balance small cells. If the fractionation included E anti-Ig rosetting, <1'7c of the low density cells had surface Ig, even after 4 d of additional culture. Without rosetting, Functional Assays. Functional assays were done in triplicate microtest wells with 1.5 × 10 ' responder T-enriched lymphocytes per flat-bottomed well (Costar, Data Packaging, Cambridge, MA) in 200 ~1 culture medium, or in round-bottomed wells (Linbro Chemical Co., Hamden, CT) in 150/zl medium. A+ leukocytes and 10% A+ human serum were used. T cells were prepared from nonadherent PBMC by En rosetting, or passage over nylon wool, as described above. For MLR assays, stimulator cells were irradiated with 3,000 rad (Cs lay, Gamma cell 1000, Atomic Energy of Canada, Ottawa, Canada). For oxidative mitogenesis, the accessory cells were irradiated, and the T cells were modified with 2 mM sodium periodate (Sigma Chemical Co.) in PBS for 30 rain at 0°C, followed by washing. Proliferation by unmodified (not periodate-treated) controls was <10% of periodate-treated samples. Proliferation was measured with 1 ~Ci [3H]thymidine in 50/~l/well (Schwarz/Mann Div., Becton, Dickinson & Co., Orangeburg, NY, 6 Ci/mM) at 104-120 h (MLR) and 56-72 h (periodate). Cells were harvested in a multisample harvester, and the data displayed as mean counts per minute ___ standard deviation of the mean. R e s u l t s A small percentage (1-2%) of adherent h u m a n P B M C had similar morphologic features to the DC isolated from mouse l y m p h o i d organs (1) . These features included: irregular shape, a b u n d a n t phase-dense granules (mitochondria), irregular nucleus with small nucleoli, and a prominent rim of heterochromatin. There were few surface ruffles, pinocytic vesicles, or lysosomes, organelles that were a b u n d a n t in adjacent monocytes (Fig. 1 a) . We first devised a multistep procedure for enriching these " c a n d i d a t e " DC. This involved successive depletion o f T cells, monocytes, and B cells. W e could then show that the cytologic, surface, and functional properties of h u m a n DC were similar to their counterparts in rodents.
Enriched Preparations of Human DC.
T h e purification of h u m a n DC was monitored by phase-contrast microscopy of specimens fixed in glutaraldehyde. At each stage of the protocol (Table I) , samples were attached to PLL-coated cover slips and incubated at 37°C to allow cells to spread. DC exhibited m a n y processes, mitochondria, and irregular nuclei ( Fig. 1 b, c) . Monocytes spread circumferentially and had clear ruffles, pinocytic vesicles, lysosomes, and oval-or kidney-shaped nuclei ( Fig. 1 d) . Small lymphocytes showed little spreading ( Fig. 1 c) , except in the case of B cells, which could form cell processes when attached to anti-Ig-coated erythrocytes. Subsequent studies with cell surface markers confirmed that these cytologic criteria were appropriate for differentiating DC, monocytes, and lymphocytes (see below).
DC enrichment required several steps and stimultaneously provided populations that were predominately monocytes, B cells, or T cells (Table I) . Mononuclear cells (<1% DC) were obtained from Ficoll-Diatrizoate columns and attached to plastic. The adherent population contained 70-90% monocytes, 5-15% lymphocytes, and <5% DC. The nonadherent fraction contained most of the T cells and small percentages of monocytes (<5%), B cells (5-10%), and DC (< 1-2%). The adherent population was cultured overnight and the once-released cells reattached to plastic. This provided an adherent fraction rich in monocytes and a nonadherent (twice-released) fraction containing B cells, most of the DC, and variable percentages (10-40%) of monocytes. The twice-released cells were then floated on dense BPA columns to obtain a high density B lymphocyte fraction and a low density population enriched in DC. Further enrichment of DC could be obtained by depleting B cells with E anti-Ig and by additional adherence to monocytes to plastic.
This procedure reproducibly provided populations that were 20-60% DC, so that a > 100-fold enrichment over PBMC had been obtained. The principle contaminating cells were monocytes (10-20%) and small cells of uncertain type that lacked B and T lymphocyte markers. Attempts to further purify DC led to unacceptable losses. We also analyzed specimens obtained from fresh venipuncture, rather than buffycoat. In 10 samples from 8 donors, we obtained a yield of low density, once-released DC corresponding to 0.3 + 0.2% of total PBMC.
Staining Techniques and Electron Microscopy. DC-enriched fractions were compared
with other cell types using several cytologic techniques. On Giemsa stain, the DC cytoplasm was a pale blue-gray, like monocytes, and lacked azurophilic granules. Both DC and lymphocytes had small numbers of lysosomes, detected by acridine orange staining, whereas all monocytes had abundant granular staining. DC and lymphocytes were peroxidase negative, whereas >80-90% of monocytes had typical peroxidase-positive granules. Finally, DC and lymphocytes were esterase negative, or had weak staining in the perinuclear region, while >80% of monocytes were strongly positive.
By transmission EM (Fig. 2 a) , the DC-enriched fraction contained small cells (-50%) with the features of lymphocytes, a minor component (<20%) of typical monocytes with many lysosomes and surface ruffles, and cells (25-40%) resembling mouse DC (Fig. 2 a) . The nuclei of presumptive DC were irregular in shape, with a thick rim of heterochromatin and small nucleoli. The surface was irregular incontour but lacked the discrete microvilli and ruffles seen on lymphocytes and monocytes. Mitochondria were numerous, but rough endoplasmic reticulum, free polysomes and ribosomes, and lysosomes were scanty. Multivesicular bodies and chains of small, smooth vesicles were noted. Birbeck granules, which are found in epidermal Langerhans cells, were not detected in either DC-or monocyte-enriched fractions.
By scanning EM (Fig. 2 b, c) 30% of the cells in the DC-enriched population had similar features to adherent mouse DC. When attached to PLL, the smooth DC surface formed many dendrites and large lamellipodia. Monocytes were entirely different in appearance because they spread circumferentially and were covered with surface folds (Fig. 2 d) . We conclude that the DC in human PBMC have similar Endocytic Capacity and Rosette Assays. DC behaved more like lymphocytes than monocytes in standard endocytic tests. DC did not phagocytose zymosan particles or latex, although some sticking of latex to DC (one to three beads per cell) was evident. In contrast, monocytes actively phagocytosed both particles. DC pinocytosed little or no horseradish peroxidase (HRP), as assessed by diaminobenzidine cytochemistry, after exposure to 1 mg/ml of enzyme for 1-2 h. Although monocytes had endogenous peroxidase activity, addition of exogenous HRP for 1 h at 37°C resulted in dramatically increased granular peroxidase staining, due to active pinocytosis.
DC and monocytes were also compared in rosette assays with appropriately modified erythrocytes (see Materials
Cell Surface Markers--Indirect Immunofluorescence.
A large group of Ab, primarily monoclonals, were used to visualize surface antigens by immunofluorescence, usually with sensitive biotin-avidin reagents (Table II) Stimulation of the Primary MLR. DC-enriched fractions were strong stimulators of both syngeneic and allogeneic primary MLR, and were at least 10 times more efficient than other cell populations on a per cell basis (Table III; each of the populations has been tested in three or more additional experiments with similar results to experiment 2). The potency of the DC-enriched fraction was not reduced after B cell depletion with E anti-human Ig rosetting (Table III, experiment 2 ). The use of BPA columns to enrich DC was not itself responsible for the activity of DC as MLR stimulators. That is, for both allogeneic and syngeneic MLR, the total stimulating activity recovered from the BPA columns was similar to the activity in the applied tw:,cereleased cells (not shown).
Other cell fractions were evaluated for MLR-stimulating activity. Contaminating DC in each fraction were enumerated by cytologic criteria. Monocyte fractions were at least 10 times less active than DC. Typically, the monocyte fractions contained 1-6% DC and 80-90% monocytes, and the DC populations had 25-40% DC and 10-25% monocytes. Therefore, stimulatory capacity correlated with Ia + DC content, rather than content of Ia + monocytes (as most monocytes are Ia +, e.g., Table II) . Nonadherent, E rosette-negative or non-T cells were 10-30 times less active than DCenriched fractions in MLR stimulation, and again, small numbers of DC (2-10%) could be identified in this population. High density B cells, obtained from the twicereleased population (Table I) were consistently 30-50 times less active than enriched DC (Table III) . However, increased stimulating capacity was noted when B cells were sedimented after E anti-Ig rosetting of twice-released cells (Table III, experiment 2) . This was not attributable to rosetting itself, because B cells that were first sedimented and then rosetted were not stimulatory (not shown). More likely, the stimulating activity was due to DC trapped during the rosetting procedure, and in fact, 1-3% nonrosetted DC were observed in the B cell fractions. Lastly, enriched-T cells were Table IV ). In four out of five experiments, monocyte populations were 10-30-fold less active than enriched DC. Monocytes did not inhibit DC when co-cultivated, unless added at high doses (20%, see Table IV , experiment 3). B and T cell fractions were again weak or inactive. We conclude that human DC, like rodent DG (2, 9), are potent accessory cells for the proliferation of periodate-modified T cells. Table I ) was divided in half and treated with bovine E or bovine E antihuman Ig, and floated in BPA. This produced two DC-enriched fractions (low density) and two B cell fractions (high density). The DC-enriched fraction with E anti-human Ig was 31% DC, 45% monocytes, and 24% small cells. The DC-enriched fraction without E anti-human Ig was 28% DC, 34% monocytes, and 38% small cells. Proliferative responses ofT cells only (no IO4) was 358 ± 157; T cells only (+ IO4) 3,418 ± 754; and for T cells (no IO4) + 5 × 104 DC was 3,856 ± 810. 
Discussion
Human blood mononuclear cells have a small subpopulation (0.1-0.5%) of DC that are virtually identical to DC in mouse and rats. Human DC were enriched to 20-60% purity and compared with enriched populations of monocytes, B cells, and T cells by several criteria. First, the morphology of DC is distinctive. DC extend smooth cytoplasmic processes in several directions, have irregularly shaped nuclei and many mitochondria, but exhibit few lysosomes or endocytic vacuoles. Second, DC express histocompatibility (HLA, HLA-DR) and leukocyte-common antigens, but lack the principle differentiation markers of monocytes (phagocytic capacity, peroxidase, esterase, Fc receptors, four surface antigens detected with monoclonal Ab), B cells (surface and intracellular Ig), and T cells (E-rosette receptor; OKT 3, 6, and 8 antigens). Third, DC are at least 10 times more active than other cells as MLR stimulators and as accessory cells for periodate-induced mitogenesis.
A clear difference between DC of man and mouse is that human DC express complement receptors, i.e., they rosette erythrocytes coated with IgM and fresh mouse serum. Complement receptors have not been detected on mouse DC with the same reagent. Conceivably this difference is related to the species or tissue studied, the possibility that the receptor in mouse may be masked or occupied by endogenous complement, or the possibility that expression of complement receptors may be associated with an activation or differentiation step.
This paper provides the first description of DC in the circulation. Circulating cells are likely to be part of a widely spread DC system. For example, we have found DC in human spleen and tonsil that are indistinguishable from blood DC in morphology, low bouyant density, and surface markers. In mice and rats, DC have been enriched from spleen and node (2-5) and can be detected in thymus, liver, and peritoneal cavity (33 and R. Steinman, unpublished observations). Hart and Fabre have visualized Ia-bearing DC in sections of all rat nonlymphoid tissues except brain (34) . Mason et al. (3) have demonstrated a substantial flux (>106 cells/d) of typical DC into the afferent lymph draining rat intestine. These DC probably are identical to Langerhans cells in the afferent lymph of guinea pigs (35) and "veiled" cells in afferent lymph of rabbits (36) . DC in all sites (lymph, lymphoid, and nonlymphoid organs) are bone marrow derived, bear Ia and leukocyte-common antigen, and lack the differentiation markers of macrophages and B cells (3, 5, 34, 37, 38) .
Relatively little is known about the kinetics and sites of DC production and their movement between different organs. Are all DC in tissues end-stage elements derived from proliferating bone marrow precursors? Can DC recirculate from one compartment to another, or at least move continuously from tissues to lymphoid organs via afferent lymph? Can DC proliferate locally in tissues, or be elicited from the marrow in increased numbers during inflammatory responses? The behavior of DC in inflammation is an important unknown, since entry of such potent accessory cells into a lesion would intensify immune responses at the local level. For example, cells resembling DC have been described in synovial tissue from patients with rheumatoid arthritis (39, 40) . In preliminary experiments on rheumatoid synovial exudates, we have found relatively large numbers of cells that have the same cytologic features and surface markers as blood DC.
There are difficulties with the study of DC from human blood compared with mouse spleen. First, it is difficult to study DC in fresh, adherent blood mononuclear cells because they are far outnumbered by B cells and monocytes. In contrast, mouse spleen adherent cells contain 10-50% DC. Second, human DC cannot be significantly enriched by density gradient separation of fresh blood mononuclear cells, because almost all monocytes are of low density as well. Mouse splenic DC are enriched by this technique because most splenic macrophages are of high density. Third, human DC cannot be enriched to the same degree of purity as mouse (>90%). The majority of the contaminating cells aresmall, Ia-bearing cells, which lack differentiation markers of B cells, T cells, and monocytes and do not differentate into these in culture. We have assumed, because of analogy to the rat and mouse, that the cells with the cytologic characteristics of DC account for the functional activity of DC-enriched fractions, but small, Ia-bearing cells may also contribute. Fourth, it is more difficult to deplete DC from human monocyte and lymphocyte fractions. Monocyte-enriched fractions contained 1-6% DC, B cells enriched with anti-Ig rosetting contained 1-4% DC, and non-T cells contained 2-10% DC. These levels of DC contamination could account for the variable functional activity of these populations.
We propose that DC are the principal MLR stimulators and accessory cells in human blood mononuclear cells, because DC fractions are much more potent than other fractions and because the small numbers of DC in the other fractions could explain their activity. Reagents that would selectively deplete human DC are needed to pursue this hypothesis. In mouse, a DC-specific cytotoxic monoclonal Ab ablates MLR-stimulating activity from mouse spleen (12) . "It is hoped that the DC-enriched populations described in this paper will be useful, as in the mouse, to immunize and screen for human DC-specific monoclonal Ab.
Summary
Previous studies demonstrated that lymphoid tissues of mice and rats contain small numbers (<1% of nucleated cells) of dendritic cells (DC) with special cytologic, surface, and functional properties. We show here that similar DC represent 0.1-0.5% of human peripheral blood mononuclear cells. DC can be enriched to 20-60% purity by a multistep procedure analogous to that used in mice. Adherent peripheral blood mononuclear cells are cultured overnight, and the released cells are depleted of monocytes and B cells by readherence to plastic, rosetting With erythrocytes coated with anti-human IgG, and centrifugation in dense albumin columns. Enriched DC have similar cytologic features to rodent DC by light and electron microscopy.
DC express HLA, and HLA-DR and the leukocyte-common antigens. They lack phagocytic capacity, receptors for antibody-coated and neuraminidase-treated erythrocytes, surface and intracellular Ig, esterase, peroxidase, and azurophilic granules. DC do not react with several monoclonal antibodies directed to phagocytes (OKM 1, "mac-l," 63D3, and 61D3) and T cells (OKT 3, 6, 8) . Unlike the mouse, human DC express complement receptors. When maintained in culture for 4 d, human DC did not give rise to either B cells or monocytes. Therefore, DC identified by cytologic criteria are distinct from other leukocytes.
Enriched populations of DC have been compared to fractions enriched in monocytes, B cells, and T cells in three functional assays: stimulation of the primary allogeneic mixed leukocyte reaction, stimulation of the primary syngeneic MLR, and accessory function for the proliferation of periodate-modified T cells. In each case, the DC fraction was 10-fold or more active than other cell fractions. We conclude that DC circulate in man, and represent the principal cell type required for the initiation of several immune responses.
